Using a network-based approach and targeted maximum likelihood estimation to evaluate the effect of adding pre-exposure prophylaxis to an ongoing test-and-treat trial

Abstract

Background:

Several cluster-randomized trials are underway to investigate the implementation and effectiveness of a universal test-and-treat strategy on the HIV epidemic in sub-Saharan Africa. We consider nesting studies of pre-exposure prophylaxis within these trials. Pre-exposure prophylaxis is a general strategy where high-risk HIV– persons take antiretrovirals daily to reduce their risk of infection from exposure to HIV. We address how to target pre-exposure prophylaxis to high-risk groups and how to maximize power to detect the individual and combined effects of universal test-and-treat and pre-exposure prophylaxis strategies.

Methods:

We simulated 1000 trials, each consisting of 32 villages with 200 individuals per village. At baseline, we randomized the universal test-and-treat strategy. Then, after 3 years of follow-up, we considered four strategies for targeting pre-exposure prophylaxis: (1) all HIV– individuals who self-identify as high risk, (2) all HIV– individuals who are identified by their HIV+ partner (serodiscordant couples), (3) highly connected HIV– individuals, and (4) the HIV– contacts of a newly diagnosed HIV+ individual (a ring-based strategy). We explored two possible trial designs, and all villages were followed for a total of 7 years. For each village in a trial, we used a stochastic block model to generate bipartite (male–female) networks and simulated an agent-based epidemic process on these networks. We estimated the individual and combined intervention effects with a novel targeted maximum likelihood estimator, which used cross-validation to data-adaptively select from a pre-specified library the candidate estimator that maximized the efficiency of the analysis.

Results:

The universal test-and-treat strategy reduced the 3-year cumulative HIV incidence by 4.0% on average. The impact of each pre-exposure prophylaxis strategy on the 4-year cumulative HIV incidence varied by the coverage of the universal test-and-treat strategy with lower coverage resulting in a larger impact of pre-exposure prophylaxis. Offering pre-exposure prophylaxis to serodiscordant couples resulted in the largest reductions in HIV incidence (2% reduction), and the ring-based strategy had little impact (0% reduction). The joint effect was larger than either individual effect with reductions in the 7-year incidence ranging from 4.5% to 8.8%. Targeted maximum likelihood estimation, data-adaptively adjusting for baseline covariates, substantially improved power over the unadjusted analysis, while maintaining nominal confidence interval coverage.

Conclusion:

Our simulation study suggests that nesting a pre-exposure prophylaxis study within an ongoing trial can lead to combined intervention effects greater than those of universal test-and-treat alone and can provide information about the efficacy of pre-exposure prophylaxis in the presence of high coverage of treatment for HIV+ persons.

Keywords

Adaptive pre-specification cluster-randomized trials HIV networks pre-exposure prophylaxis targeted maximum likelihood estimation

Get full access to this article

View all access options for this article.

References

UNAIDS. AIDS by the numbers 2015, http://www.unaids.org/en/resources/documents/2015/AIDS_by_the_numbers_2015

Cohen

Chen

McCauley

. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011; 365(6): 493–505.

World Health Organization. Guideline on when to start antiretrovial therapy and on pre-exposure prophylaxis for HIV, 2015, http://www.who.int/hiv/pub/guidelines/earlyrelease-arv/en/

The TEMPRANO ANRS 12136 Study Group. A trial of early antiretrovirals and isoniazid preventive therapy in Africa. N Engl J Med 2015; 373: 808–822.

The INSIGHT START Study Group. Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med 2015; 373(9): 795–807.

Cohen

Chen

Mccauley

. Final results of the HPTN 052 randomized controlled trial: antiretroviral therapy prevents HIV transmission. JAIDS 2015; 18(Suppl. 4): 20479.

Joint United Nations Programme on HIV/AIDS (UNAIDS). 90-90-90 an ambitious treatment target to help end the AIDS epidemic, 2014, http://www.unaids.org/en/resources/documents/2014/90-90-90

Fowler

Gable

Lampe

. Perinatal HIV and its prevention: progress toward an HIV-free generation. Clin Perinatol 2012; 37(4): 699–719, vii.

Schouten

Jahn

Midiani

. Prevention of mother-to-child transmission of HIV and the health related Millennium Development Goals: time for a public health approach. Lancet 2011; 378(9787): 282–284.

10.

French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS). Impact of immediate versus South African recommendations guided ART initiation on HIV incidence (TasP). ClinicalTrials.gov, 2011, https://clinicaltrials.gov/ct2/show/NCT01509508

11.

Centers for Disease Control and Prevention. Botswana Combination Prevention Project (BCPP). ClinicalTrials.gov, 2013, http://clinicaltrials.gov/show/NCT01965470

12.

HIV Prevention Trials Network. Population Effects of Antiretroviral Therapy to Reduce HIV Transmission (PopART). ClinicalTrials.gov, 2013, http://clinicaltrials.gov/show/NCT01900977

13.

University of California, San Francisco. Sustainable East Africa Research in Community Health (SEARCH). ClinicalTrials.gov, 2013, http://clinicaltrials.gov/show/NCT01864603

14.

Grant

Lama

Anderson

. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med 2010; 363(27): 2587–2599.

15.

Baeten

Donnell

Ndase

. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med 2012; 367(5): 399–410.

16.

Baeten

Heffron

Kidoguchi

. Integrated delivery of PrEP and ART results in sustained near elimination of HIV transmission in African HIV serodiscordant couples: final results from The Partners Demonstration Project. In: Proceedings of the 21st international AIDS conference, Durban, South Africa, 18–22 July 2016.

17.

Gill

Marcus

Dietrich

. An analysis of baseline and early data from the plus pills study: an open-label trial of pre-exposure prophylaxis for south african adolescents. In: Proceedings of the 21st international AIDS conference, Durban, South Africa, 18–22 July 2016.

18.

Dellar

Dlamini

Karim

. Adolescent girls and young women: key populations for HIV epidemic control. J Int AIDS Soc 2015; 18(Suppl. 1): 19408.

19.

Chamie

Clark

Kabami

. A hybrid mobile HIV testing approach for population-wide HIV testing in rural East Africa. Lancet HIV 2016; 3: e111–e119.

20.

Chamie

Kabami

Ssemmondo

. Population HIV testing coverage of 94% with a repeat, hybrid mobile testing strategy in rural East Africa. In: Poceedings of the conference on Retroviruses and Opportunistic Infections (CROI), Boston, MA, 22–25 February 2016.

21.

US Public Health Service. Preexposure prophylaxis for prevention of HIV infection in the United States— 2014: clincal practice guideline, 2014, https://www.cdc.gov/hiv/pdf/prepguidelines2014.pdf

22.

Henao-Restrepo

Longini

Egger

. Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial. Lancet 2015; 286(9996): 857–866.

23.

Helleringer

Kohler

. Sexual network structure and the spread of HIV in Africa: evidence from Likoma Island, Malawi. AIDS 2007; 21(17): 2323–2332.

24.

Dennis

Herbeck

Brown

. Phylogenetic studies of transmission dynamics in generalized HIV epidemics: an essential tool where the burden is greatest?JAIDS 2014; 67: 181–195.

25.

Joint United Nations Programme on HIV/AIDS (UNAIDS). The gap report. Geneva: UNAIDS, 2014.

26.

Gaolathe

Wirth

Holme

. Botswana’s progress toward achieving the 2020 UNAIDS 90-90-90 antiretroviral therapy and virological suppression goals: a population-based survey. Lancet HIV. Epub ahead of print 23 March 2016. DOI:10.1016/S2352-3018(16)00037-0.

27.

Fidler

Floyd

Yang

. Towards the second UNAIDS target: population-level ART coverage in HPTN 071 (PopART). In: Poceedings of the conference on Retroviruses and Opportunistic Infections (CROI), Boston, MA, 22–25 February 2016.

28.

Havlir

Kamya

Petersen

. SEARCH study protocol version 7.0. Technical report, Makerere University - University of California, San Francisco (MU-UCSF) Research Collaboration, February 2016.

29.

Murphy

. An experimental design for the development of adaptive treatment strategies. Stat Med 2005; 24: 1455–1481.

30.

Fisher

. The design of experiments. London: Oliver and Boyd Ltd., 1935.

31.

Collins

Dziak

Kugler

. Factorial experiments: efficient tools for evaluation of intervention components. Am J Prev Med 2014; 47(4): 498–504.

32.

Karrer

Newman

. Stochastic block models and community structure in networks. Phys Rev E 2011; 83(1): 016107.

33.

Anderson

May

Anderson

. Infectious diseases of humans: dynamics and control, vol. 28. Hoboken, NJ: Wiley Online Library, 1992.

34.

Quinn

Wawer

Sewankambo

. Viral load and heterosexual transmission of Human Immunodeficiency Virus Type 1. N Engl J Med 2000; 342(921–929).

35.

Attia

Egger

Muller

. Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS 2009; 23: 1397–1404.

36.

Lingappa

Hughes

Wang

. Estimating the impact of plasma HIV-1 RNA reductions on heterosexual HIV-1 transmission risk. PLoS ONE 2010; 5(9): e12598.

37.

Staples

. Python code for targeted PrEP in test-and-treat trials. Technical report, Harvard T.H. Chan School of Public Health, August 2016, https://github.com/ctphoenix/HIV-PrEP-Simulation

38.

Pearl

. Causality: models, reasoning and inference. New York: Cambridge University Press, 2000 (Second edition, 2009).

39.

van der Laan

Rose

. Targeted learning: causal inference for observational and experimental data. New York; Dordrecht; Heidelberg; London: Springer, 2011.

40.

Neyman

. Sur les applications de la theorie des probabilites aux experiences agricoles: Essai des principes (In Polish). English translation by Dabrowska

D.M.

Speed

T.P.

(1990). Stat Sci 1923; 5: 465–480.

41.

Rubin

. Comment: Neyman (1923) and causal inference in experiments and observational studies. Stat Sci 1990; 5(4): 472–480.

42.

Imbens

. Nonparametric estimation of average treatment effects under exogeneity: a review. Rev Econ Stat 2004; 86(1): 4–29.

43.

Imai

. Variance identification and efficiency analysis in randomized experiments under the matched-pair design. Stat Med 2008; 27(24): 4857–4873.

44.

Schochet

. Estimators for clustered education RCTs using the Neyman model for causal inference. J Educ Behav Stat 2013; 38(3): 219–238.

45.

Balzer

Petersen

van der Laan

. Targeted estimation and inference of the sample average treatment effect in trials with and without pair-matching. Stat Med 2016; 35(21): 3717–3732.

46.

Fisher

. Statistical methods for research workers. 4th ed. Edinburgh: Oliver and Boyd Ltd., 1932.

47.

Cochran

. Analysis of covariance: its nature and uses. Biometrics 1957; 13: 261–281.

48.

Cox

McCullagh

. Some aspects of analysis of covariance. Biometrics 1982; 38(3): 541–561.

49.

Tsiatis

Davidian

Zhang

. Covariate adjustment for two-sample treatment comparisons in randomized clinical trials: a principled yet flexible approach. Stat Med 2008; 27(23): 4658–4677.

50.

Moore

van der Laan

. Covariate adjustment in randomized trials with binary outcomes: targeted maximum likelihood estimation. Stat Med 2009; 28(1): 39–64.

51.

Rosenblum

van der Laan

. Simple, efficient estimators of treatment effects in randomized trials using generalized linear models to leverage baseline variables. Int J Biostat 2010; 6(1): 13.

52.

Balzer

van der Laan

Petersen

. Adaptive pre-specification in randomized trials with and without pair-matching. Stat Med 2016; 35: 4528–4545.

53.

Prague

Staples

Onnela

. Leveraging contact network information in cluster randomized trials of infectious diseases. In: Infectious disease research: quantitative methods and models in the era of big data, Bethesda, MD, 9–10 November 2015.

54.

Zheng

Balzer

Brown

. Local social network features predict HIV testing uptake in a rural Ugandan community. In: Proceedings of the conference on Retroviruses and Opportunistic Infections (CROI), Boston, MA, 22–25 February 2016.

55.

HPTN 071 (PopART) Protocol Team. HPTN 071 population effects of antiretroviral therapy to reduce HIV transmission (PopART): a cluster-randomized trial of the impact of a combination prevention package on population-level HIV incidence in Zambia and South Africa, 2015, https://www.hptn.org/research/studies/137

56.

Hayes

Moulton

. Cluster randomised trials. Boca Raton, FL: Chapman & Hall/CRC Press, 2009.

57.

Balzer

Zheng

van der Laan

. Hierarchical targeted maximum likelihood estimation: evaluating the causal effects of cluster based interventions. Technical report, University of California at Berkeley, January 2017.

58.

Balzer

. R code for targeted PrEP in test-and-treat trials. Technical report, University of California at Berkeley, May 2016, https://works.bepress.com/laura\text_balzer/36/.

59.

Eaton

Johnson

Salomon

. HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa. PLoS Med 2012; 9(7): e1001245.

60.

Abuelezam

Rough

Seage

. Individual-based simulation models of HIV transmission: reporting quality and recommendations. PLoS ONE 2013; 8(9): e75624.

61.

McCormick

Abuelezam

Rhode

. Development, calibration and performance of an HIV transmission model incorporating natural history and behavioral patterns: application in South Africa. PLoS ONE 2014; 9(5): e98272.

62.

Childs

Abuelezam

Dye

. Modelling challenges in context: lessons from malaria, HIV, and tuberculosis. Epidemics 2015; 10: 102–107.

63.

Boren

Sullivan

Beyrer

. Stochastic variation in network epidemic models: implications for the design of community level hiv prevention trials. Stat Med 2014; 33: 3894–3904.

64.

Zheng

Balzer

van der Laan

Petersen

the SEARCH Collaboration. Performance-constrained binary classification using ensemble learning: an application to cost-efficient targeted PrEP strategies. Technical Report 354, Division of Biostatistics, University of California at Berkeley October 2016.